Does TEPOTINIB Cause Interstitial lung disease? 16 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Interstitial lung disease have been filed in association with TEPOTINIB (TEPMETKO). This represents 2.4% of all adverse event reports for TEPOTINIB.
16
Reports of Interstitial lung disease with TEPOTINIB
2.4%
of all TEPOTINIB reports
6
Deaths
5
Hospitalizations
How Dangerous Is Interstitial lung disease From TEPOTINIB?
Of the 16 reports, 6 (37.5%) resulted in death, 5 (31.3%) required hospitalization.
Is Interstitial lung disease Listed in the Official Label?
Yes, Interstitial lung disease is listed as a known adverse reaction in the official FDA drug label for TEPOTINIB.
What Other Side Effects Does TEPOTINIB Cause?
Death (117)
Oedema peripheral (82)
Diarrhoea (57)
Renal impairment (57)
Oedema (56)
Fatigue (53)
Disease progression (50)
Nausea (43)
Off label use (42)
Peripheral swelling (32)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which TEPOTINIB Alternatives Have Lower Interstitial lung disease Risk?
TEPOTINIB vs TEPROTUMUMAB
TEPOTINIB vs TEPROTUMUMAB-TRBW
TEPOTINIB vs TERAZOSIN
TEPOTINIB vs TERAZOSIN\TERAZOSIN
TEPOTINIB vs TERBINAFINE